Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Pirker

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Annals of Translational Medicine|April 30, 2019
Systemic therapy of elderly patients with advanced non-small cell lung cancer-individualized treatment is keyRobert Pirker
Clinical Advances in Hematology & Oncology : H&O|November 11, 2008
Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancerRobert Pirker
Nature Reviews. Clinical Oncology|September 28, 2011
Chemotherapy: advanced NSCLC--should we use doublets in elderly patients?Robert Pirker
Expert Review of Anticancer Therapy|October 16, 2004
Darbepoetin alfa for the treatment of cancer-related anemia: an updateRobert Pirker
Current Opinion in Oncology|October 22, 2023
Immune checkpoint inhibitors as adjuvant therapy in patients with completely resected nonsmall cell lung cancerRobert Pirker
The Lancet. Oncology|July 24, 2010
Bevacizumab in lung cancer: hurdles in clinical developmentRobert Pirker
Memo|April 4, 2017
Milestones in the systemic treatment of lung cancerRobert Pirker
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Therapy of advanced non-small-cell lung cancer (take home message)Robert Pirker
The Lancet. Oncology|November 25, 2017
EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementationRobert Pirker
Expert Opinion on Drug Safety|December 22, 2006
Safety considerations for erythropoietin treatment in patients with cancerRobert Pirker
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Annals of Translational Medicine|April 30, 2019
Systemic therapy of elderly patients with advanced non-small cell lung cancer-individualized treatment is keyRobert Pirker
Clinical Advances in Hematology & Oncology : H&O|November 11, 2008
Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancerRobert Pirker
Nature Reviews. Clinical Oncology|September 28, 2011
Chemotherapy: advanced NSCLC--should we use doublets in elderly patients?Robert Pirker
Expert Review of Anticancer Therapy|October 16, 2004
Darbepoetin alfa for the treatment of cancer-related anemia: an updateRobert Pirker
Current Opinion in Oncology|October 22, 2023
Immune checkpoint inhibitors as adjuvant therapy in patients with completely resected nonsmall cell lung cancerRobert Pirker
The Lancet. Oncology|July 24, 2010
Bevacizumab in lung cancer: hurdles in clinical developmentRobert Pirker
Memo|April 4, 2017
Milestones in the systemic treatment of lung cancerRobert Pirker
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Therapy of advanced non-small-cell lung cancer (take home message)Robert Pirker
The Lancet. Oncology|November 25, 2017
EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementationRobert Pirker
Expert Opinion on Drug Safety|December 22, 2006
Safety considerations for erythropoietin treatment in patients with cancerRobert Pirker
Pageof 13